glp 1 psoriatic arthritis GLP-1 Agonists and Psoriasis: A Potential Novel Therapeutic Approach Review of GLP-1 Receptor Agonists

GIP as a therapeutic target in diabetes and obesity: insight from Incretin co-agonists

Klein S, Nestor JJ, Harris MS, Suyundikov A, Casper R, Steele SM, et al

In these patients, doctors may monitor blood sugar, HbA1c, kidney function, eye health, and the risk of hypoglycaemia, especially if insulin or sulfonylureas are also used

Report Scope Regional Analysis How Big is the North America GLP-1 Receptor Agonist Market Size

John Stanford, the executive director of Incubate Coalition, a Washington-based group of life-sciences investors, said investors are worried about diminishing exits if large drug companies have fewer funds to make acquisitions